Perspective Therapeutics, Inc.
AMEX:CATXMedical - Devices
+$0.02 today
- Market cap
- $94.67M
- Beta
- 1.73
- P/E (TTM)
- -0.0
- EPS (TTM)
- -$107.27
Volume 1.84M
Average 1.44M
Balance Sheet
Inspect the capital base behind the business.
Assets
$266.97M
FY 2025 · Annual
-21.7% YoYLiabilities
$59.94M
FY 2025 · Annual
+18.9% YoYEquity
$207.03M
FY 2025 · Annual
-28.8% YoYBalance Sheet
Metric | FY 2021 Jun 2022 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 60.35M | 20.99M | 9.24M | 61.58M | 30.63M |
| Short-term Investments | 0 | 22.76M | 0 | 165.34M | 114.11M |
| Net Receivables | 1.65M | 1.36M | 1.18M | 116K | 6K |
| Inventory | 1.07M | 1.41M | 0 | 0 | 0 |
| Other Current Assets | 535K | 6.69M | 5.35M | 4.13M | 3.65M |
| Total Current Assets | 63.6M | 53.22M | 16.84M | 231.16M | 148.39M |
| Property, Plant & Equipment (Net) | 2.62M | 2.06M | 6.32M | 59.54M | 78.1M |
| Goodwill | 0 | 0 | 24.06M | 0 | 0 |
| Intangible Assets | 107K | 86K | 50.35M | 50M | 40M |
| Long-term Investments | 0 | 150K | 133K | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 926K | (2.3M) | 182K | 405K | 486K |
| Total Non-current Assets | 3.65M | 2.3M | 81.05M | 109.94M | 118.58M |
| Total Assets | 67.25M | 58.09M | 97.89M | 341.1M | 266.97M |
| Account Payables | 847K | 1.54M | 6.91M | 10.34M | 20.51M |
| Short-term Debt | 0 | 0 | 49K | 52K | 623K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 1.4M | 26.6M |
| Other Current Liabilities | 259K | (406K) | 4.73M | 5.48M | 1.46M |
| Total Current Liabilities | 1.85M | 2.68M | 15.66M | 18.23M | 28.68M |
| Long-term Debt | 0 | 0 | 1.68M | 1.63M | 1.01M |
| Deferred Tax Liabilities | 0 | 0 | 4.59M | 2.5M | 1.7M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 26.6M | 0 |
| Other Non-current Liabilities | 624K | 75K | 4.59M | 55K | 28.56M |
| Total Non-current Liabilities | 1.02M | 331K | 7.05M | 32.2M | 31.26M |
| Total Liabilities | 2.86M | 3.45M | 22.71M | 50.43M | 59.94M |
| Common Stock | 142K | 142K | 282K | 70K | 74K |
| Retained Earnings | (95.17M) | (105.93M) | (152.44M) | (231.72M) | (334.84M) |
| Accumulated OCI | 0 | 0 | 0 | (51K) | 110K |
| Other Stockholders Equity | 0 | 160.43M | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 64.39M | 54.64M | 75.18M | 290.67M | 207.03M |
| Total Debt | 652K | 524K | 2.55M | 4.06M | 1.63M |
| Net Debt | (59.7M) | (20.99M) | (6.69M) | (57.52M) | (29M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $54.0M |
| Short-term Investments | $217.0M |
| Receivables | $58.0K |
| Other Current | $4.4M |
| Total Current Assets | $275.4M |
| PP&E (Net) | $94.9M |
| Intangible Assets | $40.0M |
| Other Non-current | $490.0K |
| Total Non-current Assets | $135.4M |
| Total Assets | $410.8M |
Analysis
Selected assets total $410.8M for Latest. The largest visible component is Short-term Investments at $217.0M, about 52.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| SC 13D/A | SC 13D/A filing | Nov 12, 2026 | |
| SC 13G | SC 13G filing | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 |
How much cash does CATX have?
Perspective Therapeutics, Inc. (CATX) reported $30.63M in cash and equivalents in fiscal 2025.
How much debt does CATX carry?
Perspective Therapeutics, Inc. (CATX) reported $1.63M of total debt, with net debt of -$29.00M.
Continue the stock analysis
Jump to another research area for this company.